Correlation Engine 2.0
Clear Search sequence regions


  • alleles (1)
  • candidiasis (3)
  • case report (1)
  • diagnosed (2)
  • disease and (1)
  • factor (2)
  • function (6)
  • humans (1)
  • mother (1)
  • patient (2)
  • proband (1)
  • protein human (1)
  • signal (1)
  • STAT (1)
  • STAT1 (8)
  • STAT3 (1)
  • STAT6 (1)
  • vascular disease (1)
  • Sizes of these terms reflect their relevance to your search.

    STAT1 gain-of-function (GOF) is a primary immune dysregulatory disorder marked by wide infectious predisposition (most notably chronic mucocutaneous Candidiasis), autoimmunity, vascular disease and malignant predisposition. While atopic features have been described in some STAT1 GOF patients, they are not considered a predominant feature of the disease. Additionally, while eosinophilic gastrointestinal infiltration has been reported in some cases, this has always been described in the context of pre-existing oropharyngeal and/or esophageal Candidiasis. Herein, we report 3 members of a multi-generational family diagnosed with STAT1 GOF caused by a novel mutation in the N-terminal domain, c.194A>C (p.D65A). The proband presented initially with a long-standing history of treatment-refractory eosinophilic esophagitis (EoE) without preceding gastrointestinal tract fungal infections, and her mother was diagnosed with esophagitis as well. EoE has been previously associated with alterations to STAT6 and STAT3 signaling pathways. The current report expands the possible association between JAK/STAT-related disorders and EoE, suggesting that EoE could be a primary disease manifestation of STAT1 GOF, even in the absence of oropharyngeal and/or esophageal Candidiasis. Copyright © 2022 Scott, Sharfe, Dadi, Vong, Garkaby, Abrego Fuentes, Willett Pachul, Nelles, Nahum and Roifman.

    Citation

    Ori Scott, Nigel Sharfe, Harjit Dadi, Linda Vong, Jenny Garkaby, Laura Abrego Fuentes, Jessica Willett Pachul, Sandra Nelles, Amit Nahum, Chaim M Roifman. Case Report: Eosinophilic Esophagitis in a Patient With a Novel STAT1 Gain-of-Function Pathogenic Variant. Frontiers in immunology. 2022;13:801832

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35126392

    View Full Text